Published in J Clin Oncol on February 01, 1999
High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol (2003) 1.57
Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells. Hum Gene Ther (2008) 1.17
Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res (2009) 1.13
Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature. Int J Colorectal Dis (2003) 1.07
Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53. Cancer Res (2013) 1.02
TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer. Ann Surg (2002) 0.98
Growth arrest-specific transcript 5 associated snoRNA levels are related to p53 expression and DNA damage in colorectal cancer. PLoS One (2014) 0.96
Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy. Int J Colorectal Dis (2003) 0.96
Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up. Int J Colorectal Dis (2008) 0.93
Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels. Br J Cancer (2007) 0.89
Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J Gastroenterol (2009) 0.88
From the genome to the proteome--biomarkers in colorectal cancer. Langenbecks Arch Surg (2007) 0.84
Usefulness of serum p53 antibody measurement in colorectal cancer: an examination of 1384 primary colorectal cancer patients. Surg Today (2013) 0.79
Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines. Br J Cancer (2001) 0.79
MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer. Clin Cancer Res (2015) 0.77
Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas. PLoS One (2012) 0.77
p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients. Afr Health Sci (2008) 0.77
Correlation between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma. BBA Clin (2014) 0.77
Serum anti-p53 antibody as a tumour marker for colorectal cancer screening. Ecancermedicalscience (2015) 0.77
Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis. Br J Cancer (2008) 0.77
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplification. Oncoscience (2015) 0.77
Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiation. Cancer Biol Ther (2015) 0.77
Correlation of p53 Overexpression with the Clinicopathological Prognostic Factors in Colorectal Adenocarcinoma. J Clin Diagn Res (2016) 0.75
Distinct pattern of mutations of conserved regions of TP53 in colorectal cancer patients in the Kashmir population: an emerging high-risk area. Ecancermedicalscience (2009) 0.75
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75
Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med (1997) 9.99
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res (2000) 4.66
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol (2002) 3.91
Selective assay of monomeric and filamentous actin in cell extracts, using inhibition of deoxyribonuclease I. Cell (1978) 3.74
Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg (2012) 3.63
Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ (1995) 3.30
Patient factors influencing the completion rate in colonoscopy. Dig Liver Dis (2005) 2.93
Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64
The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst (1996) 2.57
The impact of endoscopists' experience and learning curves and interendoscopist variation on colonoscopy completion rates. Endoscopy (2001) 2.55
The Swedish rectal cancer registry. Br J Surg (2007) 2.20
Rectal washout and local recurrence of cancer after anterior resection. Br J Surg (2010) 2.16
Randomised controlled trial of a reduced-visits programme of antenatal care in Harare, Zimbabwe. Lancet (1996) 2.15
Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol (1998) 2.09
Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum (1998) 2.09
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
Reorganization of actin in platelets stimulated by thrombin as measured by the DNase I inhibition assay. Proc Natl Acad Sci U S A (1979) 2.02
Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol (1995) 2.01
Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg (2009) 2.00
Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer (1999) 1.97
Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol (1994) 1.96
Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg (1990) 1.93
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol (2009) 1.93
Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J Natl Cancer Inst (1997) 1.91
Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg (2008) 1.87
Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum (1993) 1.87
The risk of medical complications after female circumcision. East Afr Med J (1992) 1.86
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer. Ann Oncol (2009) 1.77
Multicentre randomized clinical trial of mechanical bowel preparation in elective colonic resection. Br J Surg (2007) 1.76
Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut (2005) 1.75
Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst (1995) 1.74
Synthesis and assembly of spectrin during avian erythropoiesis: stoichiometric assembly but unequal synthesis of alpha and beta spectrin. Cell (1983) 1.70
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer (2002) 1.66
Association between sigmoid diverticulitis and left-sided colon cancer: a nested, population-based, case control study. Scand J Gastroenterol (2004) 1.65
Pre-pregnancy risk factors of small-for-gestational age births among parous women in Scandinavia. Acta Obstet Gynecol Scand (1993) 1.63
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res (1999) 1.63
A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol (2001) 1.61
Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol (1996) 1.59
Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial. Br J Surg (2013) 1.56
Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion. Eur J Clin Pharmacol (2008) 1.56
Randomized clinical trial of the effects on anal function of Milligan-Morgan versus Ferguson haemorrhoidectomy. Br J Surg (2006) 1.55
Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg (2006) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Cancer (1994) 1.54
Partogram use in the Dar es Salaam perinatal care study. Int J Gynaecol Obstet (2007) 1.51
Anorectal malignant melanoma in Sweden. Report of 49 patients. Dis Colon Rectum (1990) 1.50
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol (2004) 1.49
A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol (2001) 1.46
Dilemmas and paradoxes in providing and changing antenatal care: a study of nurses and midwives in rural Zimbabwe. Health Policy Plan (2005) 1.45
Relationship between age and survival in cancer of the colon and rectum with special reference to patients less than 40 years of age. Br J Surg (1990) 1.45
Operational factors affecting maternal mortality in Tanzania. Health Policy Plan (1997) 1.44
Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer (1999) 1.44
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol (2007) 1.44
The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy (2012) 1.44
Heparan sulfate proteoglycan of cultured cells: demonstration of a lipid- and a matrix-associated form. Biochem Biophys Res Commun (1981) 1.44
Degree of blood loss during surgery for rectal cancer: a population-based epidemiologic study of surgical complications and survival. Colorectal Dis (2014) 1.44
Population-based study of local surgery for rectal cancer. Br J Surg (2007) 1.42
[When the security requirements are fulfilled. Early discharge as an alternative to care at maternity wards]. Lakartidningen (1994) 1.40
[Follow-up after treatment of cancer must be critically evaluated]. Lakartidningen (1992) 1.39
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer (1992) 1.39
Impact of mechanical bowel preparation on survival after colonic cancer resection. Br J Surg (2014) 1.39
Intrapartum death of nonmalformed fetuses in Denmark and Sweden in 1991. A perinatal audit. Acta Obstet Gynecol Scand (1997) 1.38
Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg (2012) 1.37
A systematic overview of chemotherapy effects in breast cancer. Acta Oncol (2001) 1.36
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer (1999) 1.36
On the dynamics of the microfilament system in HeLa cells. J Cell Biol (1982) 1.34
Vimentin filaments are assembled from a soluble precursor in avian erythroid cells. J Cell Biol (1983) 1.34
Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst (1993) 1.34
A hospital study of the complications of female circumcision. Trop Doct (1991) 1.33
The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy. Ann Oncol (2011) 1.33
Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G. J Biol Chem (1988) 1.33
Association studies on 11 published colorectal cancer risk loci. Br J Cancer (2010) 1.31
Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg (2010) 1.31
Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma. Am J Pathol (1993) 1.31
Risk factors for anastomotic leakage after rectal cancer surgery: a case-control study. Colorectal Dis (2008) 1.30
A community-based investigation of avoidable factors for maternal mortality in Zimbabwe. Stud Fam Plann (1997) 1.29
Effectiveness of primary level antenatal care in decreasing anemia at term in Tanzania. Acta Obstet Gynecol Scand (1999) 1.29
Who continues to smoke while pregnant? J Epidemiol Community Health (1992) 1.29
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol (2008) 1.29
Anti-IgE antibodies in human serum: occurrence and specificity. Int Arch Allergy Appl Immunol (1981) 1.26
Maternal smoking affects fetal growth more in the male fetus. Paediatr Perinat Epidemiol (2000) 1.26
Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection. Ann Surg (1996) 1.26
Safety and efficacy of dynamic graciloplasty for fecal incontinence: report of a prospective, multicenter trial. Dynamic Graciloplasty Therapy Study Group. Dis Colon Rectum (2000) 1.24
Maternal and perinatal risk factors for childhood brain tumors (Sweden). Cancer Causes Control (1996) 1.24